Advertisement

Topics

Latest Osteoporosis NewsRSS

01:18 EDT 21st September 2017 | BioPortfolio

Biogennix Bone Graft Substitute Materials Used to Treat 6000th Patient

Irvine, California-based Biogennix, an osteobiologic company which develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, announced today that its products have now been used in more than 6000 patients. The company’s novel bone graft substitutes, osteoSPAN™ and Morpheus™ are resorbable, os...

Hypocalcemia risk comparable between denosumab, oral bisphosphonate

Incidence rates of hypocalcemia in women with postmenopausal osteoporosis are comparable between those treated with denosumab or bisphosphonate monotherapy and the rate of hypocalcemia among those treated with denosumab is consistent with the labeled risk, study data show. Leslie Spangler, PhD, of the Center for Observational Research at Amgen, and colleagues evaluated administrative data fr...

Dr. Andres Sanchez, Renown Periodontist in Eden Prairie, MN, Completes CE Course for Healing PRF Treatment

Dr. Andres Sanchez, respected periodontist in Eden Prairie, MN, recently completed a continuing education course in Paso Robles, CA, from the American College of Bio-Compatible Health. The course covered the use of platelet rich fibrin (PRF) in regenerative dentistry procedures, including bone grafting, gum grafting and dental implants. Eden Prairie, MN (PRWEB) September 20, 2017 Dr. Andres Sanch...

Stryker’s Spine Division Receives FDA Clearance for 3D-Printed Tritanium® C Anterior Cervical Cage

Stryker’s Spine division today announced that its Tritanium® C Anterior Cervical Cage, a 3D-printed interbody fusion cage intended for use in the cervical spine, has received 510(k) clearance from the U.S. Food and Drug Administration. The Tritanium C Anterior Cervical Cage is constructed from Stryker’s proprietary Tritanium In-Growth ...

Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment

The FDA has backed Kiadis Pharma’s lead blood cancer product by granting it the Regenerative Medicine Advanced Therapy designation. Kiadis Pharma, based in Amsterdam, develops products to make bone marrow transplants for the treatment of blood cancer and inherited blood disorders safer ... This awesome article Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment a...

Bone Therapeutics: Announces All Patients Meet Primary Endpoint In ALLOB Phase I/IIA Delayed-Union Study Interim Analysis

  Life Sciences Jobs   ...

Tarsa Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryTarsa Therapeutics Inc Tarsa develops therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausal osteoporosis in women at least five years post menopause. The company also offers osteoporosis treatm...

EffRx Pharmaceuticals: Binosto Data Presented at the ASBMR Congress in Denver

EffRx Pharmaceuticals SA is proud to inform that the latest safety data on Binosto® were presented as a poster on Sunday, 10th of September 2017 at the American Society for Bone and Mineral Research (ASBMR) 2017

Band-LOK Announces Allowance for Two New U.S Patents for the Tether Clamp and Implantation System

The technology is a clamp housing assembly and method for providing stabilization as a bone anchor during an orthopedic surgical procedure. Charlotte, NC (PRWEB) September 19, 2017 Band-LOK, LLC, an orthopedic medical device innovation firm focusing on band technologies for surgical applications, announced today that two new patents have been allowed by the USPTO on the proprietary Tether Clamp a...

Bone Solutions Inc. Launches OsteoCrete® Magnesium-Based Bone Void Filler

Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. (PRWEB) September 19, 2017 Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete...

Kiadis Pharma: Cellular Immunotherapy Presentation At Conference Review Of Phase I And II ATIR101 Data

AMSTERDAM-DUIVENDRECHT, The Netherlands--(BUSINESS WIRE)--Regulatory News: Kiadis Pharma N.V. (Kiadis Pharma or the Company) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative products to make bone marrow...

Is Your Foot Fracture an Early Sign of Osteoporosis?

SAN ANTONIO, Oct. 14, 2013 /PRNewswire/ -- Unexplained foot fractures may be the first sign of osteoporosis, a bone thinning disease which affects over 28 million Americans and accounts for 1.5 million bone fractures a year. According to San Antonio foot and ankle surgeon Eddie Davis, DPM, FACFAS, osteoporosis is frequently referred to as the "silent crippler" since it often progresses without an...

IRIS: Pioglitazone prevents secondary CV events in high-risk patients

Nondiabetic, insulin-resistant patients at elevated risk for stroke or MI derive a greater benefit from pioglitazone compared with those at lower risk, but fracture risk is also higher, according to a secondary analysis of data from the IRIS trial. Walter N. Kernan, MD, professor of medicine at Yale School of Medicine, and colleagues enrolled 3,876 participants (mean age, 63 years) with qual...

Telephus Medical LLC Announces CEO Mark Benedyk, PhD to Serve on Panel "Advances Against Rare and Resistant Pathogens" at Anti-Infectives Rx Invitation-Only Conference

SAN DIEGO, Sept. 18, 2017 /PRNewswire/ -- Telephus Medical LLC (Telephus), a biotechnology company focused on development of novel antibody therapies for antibiotic-resistant staphylococcal infections, today announced that CEO and President Mark Benedyk, PhD will be attending Anti-Infectives Rx, an invitation-only conference where he will be participating on an industry panel titled, "Advances Aga...

Romosozumab followed by denosumab decreases fracture risk in postmenopausal women

The risks for new vertebral, clinical and nonvertebral fractures were reduced and bone mineral density increased in postmenopausal women assigned romosozumab followed by denosumab, according to results from the FRAME extension study presented at the American Society for Bone and Mineral Research Annual Meeting.In the original FRAME study, 7,180 postmenopausal women were assigned to receive subcuta...

HbA1c levels, diabetes duration linked to fracture risk

Adults with type 2 diabetes and obesity are at increased risk for any fracture, major osteoporotic fractures and hip fractures with longer duration of diabetes and higher HbA1c levels vs. those with shorter duration and lower levels, study data show. Anna Nilsson, MD, assistant professor at the Institute of Medicine, Sahlgrenska Academy, Gothenburg University in Sweden, and colleagues evalua...

First 3D Printed Tibia Replacement

First 3D Printed Tibia Replacement Reporter: Irina Robu, PhD Current advances have allowed 3D printing of biocompatible materials, cells and supporting components into complex 3D functional living tissues. 3D bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilagino...

Radius Health Inc RDUS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryRadius Health Inc Radius Health, formerly NuVios, Inc., is a biopharmaceutical company that develops and commercializes therapeutics for osteoporosis, oncology and endocrine diseases. The company's product includes abaloparatide injection, which is used for the treatment of postmenopausal women with osteoporosis. Its clinical programs include abaloparatideSC subcutaneous injection for osteo...

TissueTech Inc. Awarded Four Patents for Proprietary Technology to Use Placental Tissue for Regenerative Medicine

Company has more than 40 issued patents TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation and the others cover methods for lyophilizing and sterilizing placental tissue. “TissueTech continues to maintain its status as the lea...

Orthopedic Braces and Supports Market Worth 4.93 Billion USD by 2022

PUNE, India, September 15, 2017 /PRNewswire/ -- According to a new market research report "Orthopedic Braces and Supports Market by Product (Lower Extremity (Knee, Foot, Ankle, Back), Upper Extremity (Shoulder, Elbow, Wrist)), Application (Ligament Injury, Preventive Care, Osteoarthritis), End User (Hospitals, OTC) - Global Forecast to 2022", published by MarketsandMarkets™, the market is pr...

Global Bone Densitometer Devices Market Research Report Forecast 20172022 [Report Updated: 19062017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Bone Densitometer Devices Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Bone Densitometer Devices industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provid...

Global Osteoporosis Partnering 2010 to 2017 [Report Updated: 01092017] Prices from USD $1495

The Global Osteoporosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals an...

University of Glasgow Release: ???Nanokicking??? Technology Enables Breakthrough In The Culture Of 3D Mineralised Bone Tissue

Researchers from the Universities of Glasgow, Strathclyde, the West of Scotland and Galway have grown three-dimensional samples of mineralised bone from human mesenchymal stem cells for the first time without typical osteoinductive media. The research, published in Nature Biomedical Engineering, is the latest advance in a technique known as ‘Nanokicking’, and is an essen...

Dr. Kevin Hogan Accepts New Patients with Missing Teeth for Dental Implants in Mt. Pleasant, SC, to Support Self Improvement Month

Dr. Kevin Hogan supports Self Improvement Month by welcoming new patients with missing teeth for single dental implants in Mt. Pleasant, SC, and All-on- 4® full-arch solutions, without a referral. (PRWEB) September 14, 2017 New patients with missing teeth are invited to celebrate Self Improvement Month by receiving All-on- 4® arch solutions or single dental implants in Mt. Pleasant, SC,...

‘Osteogenomic profile’ offers personalized fracture risk assessment

Bone mineral density-associated genetic variants may predict lifetime fracture risk for men and women, study data show.“There is a high variation in [residual lifetime risk for fracture] between individuals, and we hypothesize that the variation is partly due to genetic factors,” Thao Phuong Ho-Le, of the Centre for Health Technologies at the University of Technology Sydney in Australia, and c...

Quick Search
Advertisement
 

review and buy Osteoporosis market research data and corporate reports here